宏源药业：目前没有新的针对流感类产品研发
Hubei Hongyuan Pharmaceutical Technology Hubei Hongyuan Pharmaceutical Technology (SZ:301246) Zheng Quan Ri Bao·2025-10-31 08:41

Group 1 - The company, Hongyuan Pharmaceutical, stated on October 31 that it currently has no new research and development projects for influenza-related products [2]